PUTNAM INVESTMENTS LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 20 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,460,432
-59.4%
3,061,000
-42.0%
0.00%
-55.6%
Q3 2021$6,056,000
-41.8%
5,274,000
-40.9%
0.01%
-43.8%
Q2 2021$10,405,000
+1.7%
8,919,000
-2.3%
0.02%
-5.9%
Q1 2021$10,235,0009,133,0000.02%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Antara Capital LP 49,500,000$47,535,0001.45%
ZAZOVE ASSOCIATES LLC 16,238,000$15,254,0001.34%
Kohlberg Kravis Roberts & Co. L.P. 26,000,000$24,456,0000.22%
WEDBUSH SECURITIES INC 30,000$2,807,0000.13%
AVIVA PLC 15,000,000$14,034,0000.07%
Context Capital Management, LLC 1,000$951,0000.06%
LMR Partners LLP 4,500,000$4,242,0000.05%
CAPSTONE INVESTMENT ADVISORS, LLC 15,500,000$14,580,0000.04%
LAZARD ASSET MANAGEMENT LLC 27,770,000$26,121,0000.03%
FRANKLIN RESOURCES INC 48,000,000$45,150,0000.02%
View complete list of REVANCE THERAPEUTICS INC shareholders